Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check3 days agoChange DetectedA new publication reference was added to the Publications section, listing authors and the citation for a Phase 2b trial of inhaled imatinib for pulmonary arterial hypertension.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page revision label at the bottom was updated from v3.6.0 to v3.6.3, reflecting a newer version of the page. This update does not alter the displayed study details or interactions.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status updated to no longer look for participants, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page's heading formatting and revision tag were updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a minor update to the page's revision metadata rather than changes to the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a small update to the page version and metadata. No study data or content changes are indicated.SummaryDifference0.0%

- Check60 days agoChange DetectedThe study record for NCT05036135 shows termination with a note that AV-101 inhaled imatinib did not prove efficacy at any dose; the termination statement is included in the Study Details with the last update posted on 2024-08-23.SummaryDifference0.0%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.